<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00998907</url>
  </required_header>
  <id_info>
    <org_study_id>09/2009</org_study_id>
    <nct_id>NCT00998907</nct_id>
  </id_info>
  <brief_title>PDS*Plus and Wound Infections After Laparotomy</brief_title>
  <acronym>PDS*plus</acronym>
  <official_title>Pathway Driven Study to Evaluate the Incidence of Wound Infections and Incisional Hernias After Laparotomy and Fascial Closure With PDS*Plus Sutures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Saarland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to ascertain if the use of PDS plus® reduces the number of wound
      infections and incisional hernia after midline and transverse laparotomy comparing to
      polyglactin suture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients are treated using clinical pathways (CP) to standardise surgical procedures in
      our high volume centre. Part of the clinical process management was the standardisation of
      wound incision and abdominal wall closure.

      Wound closure is achieved using continuous absorbable loop suture. The suture length to
      incision length ratio is at least 4:1. The running sutures are 1 cm apart and at least 1.5 cm
      from the wound edge. In the first time period , the CP step for fascia closure foresees a
      triclosan-coated PDS 910 loop suture (PDS plus®, Ethicon GmbH, Norderstedt, Germany). In the
      second time period the CP step will be altered to the use of PDS loop suture (PDS II®,
      Ethicon GmbH, Norderstedt, Germany). The CP- step is changed every 100 patients to
      cluster-randomize the patients. The primary outcome is the number of wound infections.
      Together with this the number of incisional hernia will be recorded. Patients demographic and
      disease as well as procedure related data are collected in a clinical information system
      (ISHmed on SAP platform, GSD, Berlin, Germany) prospectively. Risk factors for poor wound
      healing, such as operation time, patients age, sex, body mass index, blood loss, peritonitis,
      antibiotics, and performance level classified according to the American Society of
      Anesthesiologists (ASA), are collected prospectively to compare the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of wound infections</measure>
    <time_frame>30 days after the operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number of incisional hernias.</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of incisional hernia- long time follow up</measure>
    <time_frame>12 month</time_frame>
    <description>number of incisional hernia after 24 month</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1042</enrollment>
  <condition>Wound Infection</condition>
  <condition>Incisional Hernia</condition>
  <arm_group>
    <arm_group_label>PDS II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PDS II® loop suture is used for abdominal wall closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PDS plus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>antibacterial coated &quot;PDS plus&quot; is used for abdominal wall closure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PDS plus</intervention_name>
    <description>triclosan-coated polydiaxanon 910 suture materials with antiseptic activity (PDS plus®, Ethicon GmbH, Norderstedt, Germany)</description>
    <arm_group_label>PDS plus</arm_group_label>
    <other_name>PDS plus®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PDS II</intervention_name>
    <description>polyglactin 910 suture material for abdominal wall closure</description>
    <arm_group_label>PDS II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  surgical pathologies accessed via midline or transverse abdominal incision

          -  primary fascial closure

        Exclusion Criteria:

          -  pregnancy

          -  age under 18 years

          -  open abdominal treatment

          -  known hypersensitivity against PDS/Triclosan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Justinger, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland, D-66421 Homburg/Saar, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin K Schilling, M.D., FRCS</last_name>
    <role>Study Director</role>
    <affiliation>Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland, D-66421 Homburg/Saar, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland,</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>D-66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Justinger C, Moussavian MR, Schlueter C, Kopp B, Kollmar O, Schilling MK. Antibacterial [corrected] coating of abdominal closure sutures and wound infection. Surgery. 2009 Mar;145(3):330-4. doi: 10.1016/j.surg.2008.11.007. Epub 2009 Jan 25. Erratum in: Surgery. 2009 Sep;146(3):468.</citation>
    <PMID>19231586</PMID>
  </reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <last_update_submitted>January 17, 2012</last_update_submitted>
  <last_update_submitted_qc>January 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Saarland</investigator_affiliation>
    <investigator_full_name>Christoph Justinger</investigator_full_name>
    <investigator_title>Priciple Investigator</investigator_title>
  </responsible_party>
  <keyword>Open Abdominal Surgery</keyword>
  <keyword>Fascial Closure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Incisional Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

